Boussios Stergios, Zarkavelis George, Seraj Esmeralda, Zerdes Ioannis, Tatsi Konstantina, Pentheroudakis George
Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece
Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece.
Anticancer Res. 2016 Oct;36(10):5031-5042. doi: 10.21873/anticanres.11072.
Non-epithelial ovarian cancers (NEOC) are a group of fascinating but uncommon malignancies which can be extremely challenging to treat. Collectively, these tumours only represent 10-15% of all ovarian cancers and occur in all age groups from childhood to old age. This broad term includes diverse tumours of germ cell origin, sex cord-stromal cell origin, as well as extremely rare types of ovarian cancer, such as small-cell carcinomas and sarcomas, each of which require specialist management. It is imperative that these rare tumours are managed with accurate diagnosis, staging and treatment in order to optimize patient outcomes. The aetiology and molecular origins of each sub-group of NEOC remain poorly understood and international cooperation to facilitate high quality translational research is needed. This review summarizes the published literature on the incidence, clinical presentation, pathology, therapeutic interventions, survival and prognostic factors of each sub-type of NEOC.
非上皮性卵巢癌(NEOC)是一类引人关注但并不常见的恶性肿瘤,其治疗极具挑战性。总体而言,这些肿瘤仅占所有卵巢癌的10%-15%,可发生于从儿童到老年的所有年龄组。这个宽泛的术语包括多种起源于生殖细胞、性索间质细胞的肿瘤,以及极其罕见的卵巢癌类型,如小细胞癌和肉瘤,每种都需要专科管理。为了优化患者预后,必须对这些罕见肿瘤进行准确的诊断、分期和治疗。NEOC各亚组的病因和分子起源仍知之甚少,需要开展国际合作以促进高质量的转化研究。本综述总结了已发表的关于NEOC各亚型的发病率、临床表现、病理学、治疗干预、生存率和预后因素的文献。